Stopped early
Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System
NCT02369692 · Hansen Medical · Updated 1 March 2018
- What is being tested
- Magellan Robotic 6 Fr Catheter
- For
- Peripheral Vascular Disease
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 15 people. The full rules are on the registry page.
- Where
- France
- When
- Starts or started April 2014, ends Aug 2016. Registered 24 Feb 2015.
- Results
- None posted yet.
In the researchers' words
The purpose of this prospective study is to gather procedural use and safety data on the initial use of the Magellan Robotic System with the Magellan Robotic Catheter 6 Fr, Vascular Accessories 6 Fr and Microcatheter Driver This study will focus on, but not be limited to, endovascular embolization procedures in the peripheral vascular, for example, embolization of the splenic and hepatic arteries, uterine arterial embolization (UAE), prostatic arterial embolization (PAE), and trans-arterial chemoembolization (TACE). The data will be analyzed for medical education, societal presentation and/or publication by the investigator.
Sites
- Hôpital Européen Georges PompidouParis, France